- Home
- VYGR vs OUST Comparison
VYGR vs OUST Comparison
Compare VYGR & OUST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VYGR
- OUST
- Stock Information
- Founded
- VYGR 2013
- OUST 2015
- Country
- VYGR United States
- OUST United States
- Employees
- VYGR N/A
- OUST N/A
- Industry
- VYGR Biotechnology: Pharmaceutical Preparations
- OUST Industrial Machinery/Components
- Sector
- VYGR Health Care
- OUST Technology
- Exchange
- VYGR Nasdaq
- OUST Nasdaq
- Market Cap
- VYGR 386.1M
- OUST 422.4M
- IPO Year
- VYGR 2015
- OUST N/A
- Fundamental
- Price
- VYGR $5.43
- OUST $8.98
- Analyst Decision
- VYGR Strong Buy
- OUST Strong Buy
- Analyst Count
- VYGR 8
- OUST 5
- Target Price
- VYGR $17.00
- OUST $12.60
- AVG Volume (30 Days)
- VYGR 583.2K
- OUST 1.3M
- Earning Date
- VYGR 11-12-2024
- OUST 11-07-2024
- Dividend Yield
- VYGR N/A
- OUST N/A
- EPS Growth
- VYGR N/A
- OUST N/A
- EPS
- VYGR 0.47
- OUST N/A
- Revenue
- VYGR $163,784,000.00
- OUST $105,453,000.00
- Revenue This Year
- VYGR N/A
- OUST $35.77
- Revenue Next Year
- VYGR N/A
- OUST $38.06
- P/E Ratio
- VYGR $11.65
- OUST N/A
- Revenue Growth
- VYGR 3.40
- OUST 51.14
- 52 Week Low
- VYGR $5.19
- OUST $4.65
- 52 Week High
- VYGR $11.72
- OUST $16.88
- Technical
- Relative Strength Index (RSI)
- VYGR 34.18
- OUST 58.45
- Support Level
- VYGR $5.19
- OUST $8.50
- Resistance Level
- VYGR $5.59
- OUST $9.68
- Average True Range (ATR)
- VYGR 0.41
- OUST 0.77
- MACD
- VYGR -0.19
- OUST 0.03
- Stochastic Oscillator
- VYGR 10.71
- OUST 53.08
About VYGR Voyager Therapeutics Inc.
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.
About OUST Ouster Inc.
Ouster Inc is a provider of lidar sensors for the automotive, industrial, robotics, and smart infrastructure industries. Ouster's products include high-resolution scanning and solid-state digital lidar sensors, Velodyne Lidar sensors, and software solutions. The company operates in the Americas, Asia and Pacific, Europe, Middle East, and Africa regions. It derives maximum revenue from Americas.